Prolongation of follicular phase by delaying hCG administration results in a higher incidence of endometrial advancement on the day of oocyte retrieval in GnRH antagonist cycles

By Kolibianakis Efstratios M.   Bourgain Claire   Papanikolaou Evangelos G.   Camus Michel   Tournaye Herman   Van Steirteghem André C.   Devroey Paul  

Human Reproduction, Vol. 20, Iss. 9, 2005-09 ,pp. : 2453-2456

Oxford University Press

Access to resources Recommend Favorite

Can 200 IU of hCG replace recombinant FSH in the late follicular phase in a GnRH-antagonist cycle? A pilot study

By Blockeel C.   De Vos M.   Verpoest W.   Stoop D.   Haentjens P.   Devroey P.  

Human Reproduction, Vol. 24, Iss. 11, 2009-11 ,pp. : 2910-2916

Oxford University Press

Access to resources Recommend Favorite

GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study

By Humaidan P.  

Human Reproduction, Vol. 20, Iss. 5, 2005-05 ,pp. : 1213-1220

Oxford University Press

Access to resources Recommend Favorite

Reply: GnRH agonist (buserelin) or hCG for ovulation induction in gnRH antagonist IVF/ICSI cycles: a prospective randomized study

By Humaidan Peter  

Human Reproduction, Vol. 20, Iss. 11, 2005-11 ,pp. : 3260-3260

Oxford University Press

Access to resources Recommend Favorite

Prognostic value of serum progesterone and LH values on the day of hCG administration in IUI GnRH antagonist cycles

By Matorras R.   Soler A. Valls i   Ramon O.   Burgos J.   Abanto E.   González M.   Múgica J.   Corcóstegui B.   Pijoan J.I.   Exposito Antonia  

Gynecological Endocrinology, Vol. 28, Iss. 3, 2012-03 ,pp. : 157-161

Informa Healthcare

Access to resources Recommend Favorite